Hem › Crohns sjukdom › Michigan
Kliniska studier för Crohns sjukdom i Michigan
20 studier för Crohns sjukdom söker deltagare vid platser i Michigan.
Städer i Michigan
Officiell studietext (engelska)
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
- St. Joseph Mercy Hospital - Huron Gastroenterology Associates ( Site 0287), Ypsilanti
RekryterarFas 3
Alla åldrar · Alla kön · Uppdaterad 2 okt. 2026 · NCT06651281A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
- University of Michigan ( Site 5060), Ann Arbor
- Clinical Research Institute of Michigan, LLC ( Site 5002), Clinton Township
RekryterarFas 3
Ålder 16 till 80 · Alla kön · Uppdaterad 2 okt. 2026 · NCT06430801Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- West Michigan Clinical Research Center /ID# 280480, Wyoming
RekryterarFas 2
Ålder 18 till 75 · Alla kön · Uppdaterad 2 okt. 2026 · NCT07697456A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- Gastroenterology Associates of Western Michigan, P.L.C., Wyoming
- Huron Gastro, Ypsilanti
RekryterarFas 4
Ålder 18 till 80 · Alla kön · Uppdaterad 30 sep. 2026 · NCT06581328Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
- Henry Ford Medical Center - Columbus /ID# 266503, Novi
RekryterarFas 2
Ålder 18 till 75 · Alla kön · Uppdaterad 25 sep. 2026 · NCT06548542A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
- Michigan Center of Medical Research, Farmington Hills
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT07499232An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
- Henry Ford Medical Center - Columbus-Site Number: 8400118, Novi
- Gastroenterology Associates of Western Michigan-Site Number: 8400060, Wyoming
RekryterarFas 3
Ålder 16 till 80 · Alla kön · Uppdaterad 23 sep. 2026 · NCT07184931A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
- Gastroenterology Associates of Western Michigan, PLC d.b.a. West Michigan Clinical Research Center, Wyoming
RekryterarFas 2
Ålder 18 till 80 · Alla kön · Uppdaterad 22 sep. 2026 · NCT07483073A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
- Gastroenterology Associates of Western Michigan, PLC d.b.a. West Michigan Clinical Research Center, Wyoming
RekryterarFas 2
Ålder 18 till 80 · Alla kön · Uppdaterad 22 sep. 2026 · NCT07483099A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
- Huron Gastroenterology Associates, P.C., Ypsilanti
RekryterarFas 4
Ålder 18 till 70 · Alla kön · Uppdaterad 9 sep. 2026 · NCT06045754A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
- Michigan Center of Medical Research, Farmington Hills
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 28 aug. 2026 · NCT07577843A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
- Children's Hospital of Michigan, Detroit
RekryterarFas 3
Ålder 2 till 17 · Alla kön · Uppdaterad 3 aug. 2026 · NCT06100289Developing a Self-Management Intervention to Improve Health Outcomes for Patients With Inflammatory Bowel Disease
- University of Micigan, Ann Arbor
Rekryterar
Ålder 18 och äldre · Alla kön · Uppdaterad 23 juli 2026 · NCT07456566A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- Childrens Hospital of Michigan, Detroit
RekryterarFas 3
Ålder 2 till 17 · Alla kön · Uppdaterad 22 juni 2026 · NCT06405087Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease
- University of Michigan, Ann Arbor
RekryterarFas 4
Ålder 6 till 17 · Alla kön · Uppdaterad 27 maj 2026 · NCT05781152Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
- Henry Ford Columbus Center, Detroit
RekryterarFas 2
Ålder 18 till 75 · Alla kön · Uppdaterad 27 apr. 2026 · NCT06456593A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease
- Investigational Site Number: 8400008, Wyoming
RekryterarFas 2
Ålder 18 till 75 · Alla kön · Uppdaterad 27 mars 2026 · NCT06958536A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Mirador Therapeutics Selected Site, Ypsilanti
RekryterarFas 2
Ålder 18 till 80 · Alla kön · Uppdaterad 12 mars 2026 · NCT07113522A Pilot Study Examining Low Sulfur Diet as Treatment for Persistent Symptoms in Quiescent Crohn's Disease
- University of Michigan, Ann Arbor
Rekryterar
Ålder 18 och äldre · Alla kön · Uppdaterad 15 jan. 2026 · NCT05849012Treatment of Moderate to Severe Refractory Crohn's Disease
- University of Michigan, Ann Arbor
RekryterarFas 1/2
Ålder 18 till 65 · Alla kön · Uppdaterad 10 dec. 2025 · NCT06721962Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.